$QTZM News

Quantumzyme to Engage With Industry Leaders at BioLogic Summit 2026, Reinforcing Commitment to AI-Driven Innovation

Quantumzyme Announces Board Approval for Strategic Name Change to Quantum Genesis AI

Quantumzyme to Showcase Sustainable Enzyme Engineering Innovations at CCE-2026

Quantumzyme Announces First Lab-Scale Sample of Green Ibuprofen Shipped for Industrial Validation

Quantumzyme Expands AI-Driven Enzyme Engineering Platform to Broaden Green API Manufacturing Applications

Quantumzyme Announces Publication of Green Ibuprofen Process in RSC Sustainability

Quantumzyme Announces Publication of Patents Supporting Sustainable Pharmaceutical Growth & Innovation

Quantumzyme Corp. Participated in Enzyme Engineering XXVIII Conference in Denmark

Quantumzyme Corp. Announces USPTO Publication of Breakthrough Ibuprofen Patent

Quantumzyme Announces Removal of OTC Markets Caveat Emptor Designation

Quantumzyme Responds to OTC Markets Caveat Emptor Designation and Denounces Unauthorized Promotion Activity

Quantumzyme Highlights Benefits and Commercialization Opportunities of Pending Breakthrough Green Chemistry Patent

Quantumzyme Anticipates Publication of Transformative Patent for Enzymatic Ibuprofen Manufacturing

Quantumzyme Highlights Enzyme Engineering Platform and Ongoing Work in Sustainable Ibuprofen Synthesis

Quantumzyme: Advancing Enzymatic Innovation for a Sustainable Industrial Future

Quantumzyme Introduces Manu Bharath Khareedhi as Independent Director, Looks to Strengthen Strategic Growth and Innovation

Quantumzyme Signs MOU With Zummit Africa to Establish a Centre of Excellence in AI for Green Chemistry

Quantumzyme to Become Fully Reporting SEC Issuer, Unlocking New Growth Potential

Quantumzyme Highlights Breakthroughs in Enzymatic Catalysis at CCE 2025

Quantumzyme Announces Vision to Lead the Future of Sustainable Industrial Biocatalysis